Essential Fatty Acids Preparation (Sr-3) Improves Alzheimer's Patients Quality of Life
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
In a number of previous reports we showed the salutary effects on rats of SR-3, a compound comprising a 1:4 ratio of n-3 and n-6 fatty acids. Improvements were noted in learning tasks, thermoregulation, recovery from neurotoxins, and seizure protection. Because we were impressed that these effects are related to changes in membrane fluidity and neuronal functioning and because Alzheimer's Disease is also associated with lipid defects, we undertook a short term (4 week) double blind study with 100 Alzheimer patients (60 received SR-3 and 40 in a placebo control). The results indicated improvements in mood, cooperation, appetite, sleep, ability to navigate in the home, and short term memory. Overall improvement was reported for 49 patients, and in no case did a guardian report adverse effects to the compound. While not uniform or permanent, and while no mode of action for SR-3 can be precisely identified at this time, the promising results in quality of life for the patient and caregiver warrant further clinical trials and continued basic research into the neuropsychological substrate of the disease and its response to SR-3.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autopsy Samples of Alzheimer's Cortex Show Increased Peroxidation In Vitro
Subbarao, K. V., Richardson, J. S., & Ang, L. C. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08858.x · Cited by 463
Cited by
HEALTH BENEFITS OF DOCOSAHEXAENOIC ACID (DHA)
HORROCKS, L. A., & YEO, Y. K. (1999) · Pharmacological Research · doi:10.1006/phrs.1999.0495 · Cited by 1,031
A review of fatty acid profiles and antioxidant content in grass-fed and grain-fed beef
Daley, C. A., Abbott, A., Doyle, P. S., Nader, G. A., & Larson, S. (2010) · Nutrition Journal · doi:10.1186/1475-2891-9-10 · Cited by 807
Freund-Levi, Y., Eriksdotter-Jönhagen, M., Cederholm, T., Basun, H., Faxén-Irving, G., Garlind, A., Vedin, I., Vessby, B., Wahlund, L.-O., & Palmblad, J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1402 · Cited by 751
Caloric restriction improves memory in elderly humans
Witte, A. V., Fobker, M., Gellner, R., Knecht, S., & Flöel, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808587106 · Cited by 574
Conquer, J. A., Tierney, M. C., Zecevic, J., Bettger, W. J., & Fisher, R. H. (2000) · Lipids · doi:10.1007/s11745-000-0646-3 · Cited by 524
Janssen, C. I. F., & Kiliaan, A. J. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.10.002 · Cited by 514
Essential Fatty Acids and the Brain
Haag, M. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304800308 · Cited by 421
Chiu, C.-C., Su, K.-P., Cheng, T.-C., Liu, H.-C., Chang, C.-J., Dewey, M. E., Stewart, R., & Huang, S.-Y. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.05.015 · Cited by 406
Effect of fish oil on cognitive performance in older subjects: A randomized, controlled trial
van de Rest, O., Geleijnse, J. M., Kok, F. J., van Staveren, W. A., Dullemeijer, C., OldeRikkert, M. G. M., Beekman, A. T. F., & de Groot, C. P. G. M. (2008) · Neurology · doi:10.1212/01.wnl.0000324268.45138.86 · Cited by 382
Fotuhi, M., Mohassel, P., & Yaffe, K. (2009) · Nature Reviews Neurology · doi:10.1038/ncpneuro1044 · Cited by 344
Diet and risk of dementia: Does fat matter?: The Rotterdam Study
Engelhart, M. J., Geerlings, M. I., Ruitenberg, A., van Swieten, J. C., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2002) · Neurology · doi:10.1212/01.wnl.0000038345.77753.46 · Cited by 324
Kitajka, K., Puskás, L. G., Zvara, Á., Hackler, L., Barceló-Coblijn, G., Yeo, Y. K., & Farkas, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042698699 · Cited by 323
Neurological Benefits of Omega-3 Fatty Acids
Dyall, S. C., & Michael-Titus, A. T. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8036-z · Cited by 311
Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case–control study
Tully, A. M., Roche, H. M., Doyle, R., Fallon, C., Bruce, I., Lawlor, B., Coakley, D., & Gibney, M. J. (2003) · British Journal of Nutrition · doi:10.1079/bjn2002804 · Cited by 309
Sinn, N., Milte, C. M., Street, S. J., Buckley, J. D., Coates, A. M., Petkov, J., & Howe, P. R. C. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511004788 · Cited by 297
“There are some reports of benefit((16,17)).”
The Effects of Dietary Nutrition on Sleep and Sleep Disorders
Zhao, M., Tuo, H., Wang, S., & Zhao, L. (2020) · Mediators of Inflammation · doi:10.1155/2020/3142874 · Cited by 275
Effects of omega-3 fatty acids on cognitive performance: a meta-analysis
Mazereeuw, G., Lanctôt, K. L., Chau, S. A., Swardfager, W., & Herrmann, N. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.12.014 · Cited by 253
Lee, L. K., Shahar, S., Chin, A.-V., & Yusoff, N. A. M. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2848-0 · Cited by 219
Phillips, M., Childs, C., Calder, P., & Rogers, P. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161024600 · Cited by 149
“Improvements in Mini Mental State Examination (MMSE) score and quality of life were found when supplementing EPA or a combination of omega-3 and -6 PUFAs to patients with AD [8,9].”
BackgroundPharmacotherapies for sleep disturbances in dementia
McCleery, J., & Sharpley, A. L. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009178.pub4 · Cited by 128
Sinn, N., Milte, C., & Howe, P. R. C. (2010) · Nutrients · doi:10.3390/nu2020128 · Cited by 115
Low Plasma N-3 Fatty Acids and Dementia in Older Persons: The InCHIANTI Study
Cherubini, A., Andres-Lacueva, C., Martin, A., Lauretani, F., Iorio, A. D., Bartali, B., Corsi, A., Bandinelli, S., Mattson, M. P., & Ferrucci, L. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.10.1120 · Cited by 95
“Small clinical trials found positive effects of treatment with DHA both in patients suffering from AD (29) and in those suffering from vascular dementia (30).”
N-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for Psychopathology
Pusceddu, M. M., Kelly, P., Stanton, C., Cryan, J. F., & Dinan, T. G. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw078 · Cited by 70
B vitamins and n-3 fatty acids for brain development and function: review of human studies
van de Rest, O., van Hooijdonk, L. W. A., Doets, E., Schiepers, O. J. G., Eilander, A., & de Groot, L. C. P. G. M. (2012) · Annals of Nutrition and Metabolism · doi:10.1159/000337945 · Cited by 70
Raz, R., Carasso, R. L., & Yehuda, S. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.070 · Cited by 67
“First, it uses short-chain EFA, which were not seriously tested before in ADHD, using a ratio that has already proven to be better than placebo in several conditions (Yehuda and Carasso 1993; Yehuda et al. 1996; Mostofsky et al. 2000; Yehuda et al. 2003;Yehuda et al. 2005).”
Self-citationJeng, J.-Y., Lee, W.-H., Tsai, Y.-H., Chen, C.-Y., Chao, S.-Y., & Hsieh, R.-H. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf902021h · Cited by 24
Bourre, J. M. (2009) · Food for the Ageing Population · doi:10.1533/9781845695484.2.219 · Cited by 11
Metadata
- Authors
- Yehuda, S., Rabinovtz, S., Carasso, R. L., & Mostofsky, D. I.
- Venue
- International Journal of Neuroscience
- Publisher
- Informa UK Limited
- Published
- 1996-01
- Volume
- 87
- Issue
- 3-4
- Pages
- 141-149
- ISSN
- 0020-7454 (ISSN-L)
- 1543-5245
- OpenAlex
- W1967540204
- Cited by
- 142
- References
- 1
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.